Pharmacological treatment of Multiple sclerosis

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorNahhas, Rami
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2019-09-24T10:50:43Z
dc.date.available2019-09-24T10:50:43Z
dc.date.created2019-04-05
dc.description.abstractMultiple Sclerosis is a chronic immune-mediated inflammatory disease of the Central nervous system, involving both a demyelinating and a neurodegenerative processes and resulting in a wide range of sensory, motor, cognitive and even psychiatric symptoms. Although MS is considered a rare disease involving just a couple of million individuals worldwide, it is the most common immune-mediated disease involving the central nervous system. The etiology and risk factors of the disease are unclear but many theories and studies have related it to various conditions, infections, and genetic predispositions. Multiple sclerosis can take many forms, the most common of which is the relapsing- remitting form, which causes the symptoms and the diagnostic findings to be dissociated in both time and space. There is no known cure for multiple sclerosis, though several therapies have proven helpful. The management of the disease involves treatment of acute attacks, symptomatic therapies, and disease modifying drugs, that last one is considered challenging because of the unclear pathophysiology of the disease and the adverse effects of the drugs. the goal of the treatment is preventing new attacks, preventing disabilities and restoring function after an attack. The prognosis of MS depends on many factors such as the type of the disease, sex and age.hu_HU
dc.description.correctorLB
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent92hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/273684
dc.language.isoenhu_HU
dc.subjectMultiple sclerosishu_HU
dc.subjectFingolimod
dc.subjectDimethyl fumarate autoimmune
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titlePharmacological treatment of Multiple sclerosishu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)